Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Kyriakos A Kirou"'
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/c29d05133a9d44c8a43d0175d2795d30
Autor:
Mary K Crow, Kyriakos A Kirou, Mikhail Olferiev, Dina Greenman, Jeffrey Zhang-Sun, David Fernandez
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/a28de8affae14e089d99527427e11b5c
Autor:
Mary K Crow, Kyriakos A Kirou, Mikhail Olferiev, Dina Greenman, Jeffrey Zhang-Sun, David Fernandez
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/bbb451f151bb47d4995275ec70260e37
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Treatment of systemic lupus erythematosus (SLE) currently employs agents with relatively unselective immunosuppressive properties. However, two target-specific biological drugs have been approved: belimumab (anti-B-cell-activating factor/BAFF) and an
Externí odkaz:
https://doaj.org/article/891e2553fbcb462c80e79695e839c6c8
Publikováno v:
Lupus Nephritis.
Autor:
Mikhail Olferiev, Dina Greenman, Jeffrey Zhang-Sun, David Fernandez, Kyriakos A Kirou, Mary K Crow
Publikováno v:
Transcriptomics.
Publikováno v:
Rheumatology.
Objectives To investigate the expression of type I IFN (IFN-I) and neutrophil transcripts in kidney tissue from patients with different classes of LN and their association with distinct clinical and histopathological features. Methods Quantitation of
Autor:
Vidyanath Chaudhary, Marie Dominique Ah Kioon, Sung-Min Hwang, Bikash Mishra, Kimberly Lakin, Kyriakos A. Kirou, Jeffrey Zhang-Sun, R. Luke Wiseman, Robert F. Spiera, Mary K. Crow, Jessica K. Gordon, Juan R. Cubillos-Ruiz, Franck J. Barrat
Publikováno v:
Journal of Experimental Medicine. 219
Plasmacytoid dendritic cells (pDCs) chronically produce type I interferon (IFN-I) in autoimmune diseases, including systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). We report that the IRE1α-XBP1 branch of the unfolded protein respons
Autor:
Wendy Gao, Margie Byron, Betty Diamond, Diane L. Kamen, Maria Dall'Era, Cynthia Aranow, Anca D. Askanase, Amit Saxena, Susan A. Boackle, Kristin Ryker, Linna Ding, Patti Tosta, Sai Kanaparthi, Kristina M. Harris, Samir V. Parikh, Kyriakos A. Kirou, Maureen McMahon, S. Sam Lim, William F. Pendergraft, David Wofsy, Dawn E. Smilek, W. Winn Chatham, Susan Malkiel, Amber S. Podoll, Bradley Marder, Y Atisha-Fregoso, William T. Barry, David R. Karp
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis Rheumatol
Arthritis Rheumatol
Objective To assess the safety, mechanism of action, and preliminary efficacy of rituximab followed by belimumab in the treatment of refractory lupus nephritis (LN). Methods In a multicenter, randomized, open-label clinical trial, 43 patients with re
Autor:
Lisa R. Sammaritano, Jackie Szymonifka, Lisa A. Mandl, Alana B. Levine, Shanthini Kasturi, Jessica R. Berman, Kyriakos A. Kirou
Publikováno v:
BASE-Bielefeld Academic Search Engine
Objective To evaluate the longitudinal responsiveness (sensitivity to change) of the Patient-Reported Outcomes Measurement Information Systems (PROMIS® ) global health short form (PROMIS10) in outpatients with systemic lupus erythematosus (SLE). Met